| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.088 | 0.007 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.008 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.084 | 0.008 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.12 | 0.008 |